Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2025-01-03 00:00:00 ET · period of report 2025-01-01 · accession 0001415889-25-000426 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-03 | 2025-01-01 | FBIO | Lorenz Kevin | Dir | A - Grant | $0.00 | +49.4K | 73.7K | +203% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common stock, par value $0.001 | 2025-01-01 | A | A | 49,383 | $0.00 | 73,687 | D | — | — | (F1) The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. |